350 related articles for article (PubMed ID: 27666661)
1. Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).
Zhang J; Li M; Yao Z
Mol Med Rep; 2016 Nov; 14(5):4023-4029. PubMed ID: 27666661
[TBL] [Abstract][Full Text] [Related]
2. Legius Syndrome and its Relationship with Neurofibromatosis Type 1.
Denayer E; Legius E
Acta Derm Venereol; 2020 Mar; 100(7):adv00093. PubMed ID: 32147744
[TBL] [Abstract][Full Text] [Related]
3. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
4. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic and clinical significance of café-au-lait macules.
Shah KN
Pediatr Clin North Am; 2010 Oct; 57(5):1131-53. PubMed ID: 20888463
[TBL] [Abstract][Full Text] [Related]
6. Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus.
Ahlbom BE; Dahl N; Zetterqvist P; Annerén G
Clin Genet; 1995 Aug; 48(2):85-9. PubMed ID: 7586657
[TBL] [Abstract][Full Text] [Related]
7. Café au Lait Macules and Associated Genetic Syndromes.
Anderson S
J Pediatr Health Care; 2020; 34(1):71-81. PubMed ID: 31831114
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
Yao R; Wang L; Yu Y; Wang J; Shen Y
J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
[TBL] [Abstract][Full Text] [Related]
9. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.
Castellanos E; Rosas I; Negro A; Gel B; Alibés A; Baena N; Pineda M; Pi G; Pintos G; Salvador H; Lázaro C; Blanco I; Vilageliu L; Brems H; Grinberg D; Legius E; Serra E
Clin Genet; 2020 Feb; 97(2):264-275. PubMed ID: 31573083
[TBL] [Abstract][Full Text] [Related]
11. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins.
Nyström AM; Ekvall S; Strömberg B; Holmström G; Thuresson AC; Annerén G; Bondeson ML
Acta Paediatr; 2009 Apr; 98(4):693-8. PubMed ID: 19120036
[TBL] [Abstract][Full Text] [Related]
12. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
[TBL] [Abstract][Full Text] [Related]
13. Multiple café au lait spots in familial patients with MAP2K2 mutation.
Takenouchi T; Shimizu A; Torii C; Kosaki R; Takahashi T; Saya H; Kosaki K
Am J Med Genet A; 2014 Feb; 164A(2):392-6. PubMed ID: 24311457
[TBL] [Abstract][Full Text] [Related]
14. Multiple café au lait macules and Crowe sign.
López Aventín D; Gilaberte M; Pujol RM
Arch Dermatol; 2011 Jun; 147(6):735-40. PubMed ID: 21690543
[No Abstract] [Full Text] [Related]
15. Café au lait spots: When and how to pursue their genetic origins.
Lalor L; Davies OMT; Basel D; Siegel DH
Clin Dermatol; 2020; 38(4):421-431. PubMed ID: 32972601
[TBL] [Abstract][Full Text] [Related]
16. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
17. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
18. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
19. PTPN11 gene mutations: linking the Gln510Glu mutation to the "LEOPARD syndrome phenotype".
Digilio MC; Sarkozy A; Pacileo G; Limongelli G; Marino B; Dallapiccola B
Eur J Pediatr; 2006 Nov; 165(11):803-5. PubMed ID: 16733669
[TBL] [Abstract][Full Text] [Related]
20. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
Wimmer K; Rosenbaum T; Messiaen L
Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
